Literature DB >> 20021573

Recurrences, vaccinations and long-term symptoms in GBS and CIDP.

Krista Kuitwaard1, Martine E Bos-Eyssen, Patricia H Blomkwist-Markens, Pieter A van Doorn.   

Abstract

We determined the frequency of recurrent Guillain-Barré syndrome (GBS), whether vaccinations led to recurrences of GBS or an increase of disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and we assessed the prevalence of pain, fatigue and the impact on quality of life after GBS and CIDP. Additionally, we assessed the presence of common auto-immune disorders. Four hundred and sixty-one members of the Dutch society of neuromuscular disorders received a questionnaire. Two hundred and forty-five GBS and seventy-six CIDP patients were included (response rate 70%). Nine patients had a confirmed recurrent GBS, and two patients had experienced both GBS and CIDP. Common auto-immune diseases were reported in 9% of GBS and 5% of CIDP patients. None of the 106 GBS patients who received a flu vaccination (range 1-37 times, total 775 vaccinations) reported a recurrence thereafter. Five out of twenty-four CIDP patients who received a flu vaccination (range 1-17 times) reported an increase in symptoms. Pain or severe fatigue was reported in about 70% of patients after the diagnosis of GBS (median 10 years) or after onset of CIDP (median 6 years), and quality of life was significantly reduced. Flu vaccinations seem relatively safe. GBS and CIDP patients often experience pain, fatigue and a reduced quality of life for many years after the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20021573     DOI: 10.1111/j.1529-8027.2009.00243.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  28 in total

Review 1.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

2.  Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment.

Authors:  P G Sanz; C V García Méndez; A L Cueto; V B Silva; J C Walther; R A Diez; S Martins; R J Giannaula
Journal:  Rheumatol Int       Date:  2011-09-16       Impact factor: 2.631

Review 3.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

Review 4.  Immune-mediated adverse reactions to vaccines.

Authors:  Cosby A Stone; Christine R F Rukasin; Thomas M Beachkofsky; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2019-11-05       Impact factor: 4.335

5.  Selective digestive tract decontamination decreases time on ventilator in Guillain-Barré syndrome.

Authors:  Martine E Bos Eyssen; Pieter A van Doorn; Bart C Jacobs; Ewout W Steyerberg; Peter H J van der Voort; Durk F Zandstra; Janneke Horn; Peter E Spronk; Cornelia W Hoedemaekers; Jan Bakker; Mathieu van der Jagt
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 6.  [Guillain-Barré syndrome after exposure to influenza].

Authors:  H-P Hartung; B Keller-Stanislawski; R A Hughes; H C Lehmann
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

7.  A Rare Case of COVID-19-Induced Chronic Demyelinating Polyneuropathy.

Authors:  Dhaval Patel; Gaurav Mandal; Lawrence Chukwueke; Kenneth Woods
Journal:  Cureus       Date:  2022-05-20

8.  Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Authors:  Merel C Broers; Carina Bunschoten; Daan Nieboer; Hester F Lingsma; Bart C Jacobs
Journal:  Neuroepidemiology       Date:  2019-01-22       Impact factor: 3.282

Review 9.  COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.

Authors:  Arens Taga; Giuseppe Lauria
Journal:  J Peripher Nerv Syst       Date:  2022-03-14       Impact factor: 5.188

10.  Neuroimmunology of depression.

Authors:  Erika Sarno; Adam J Moeser; Alfred J Robison
Journal:  Adv Pharmacol       Date:  2021-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.